AZI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.408600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.075000E-01
Normal-vs-Stage2
7.538800E-01
Normal-vs-Stage3
9.769600E-02
Normal-vs-Stage4
4.268600E-01
Stage1-vs-Stage2
5.665600E-01
Stage1-vs-Stage3
3.064000E-01
Stage1-vs-Stage4
1.438620E-01
Stage2-vs-Stage3
1.101760E-01
Stage2-vs-Stage4
2.200800E-01
Stage3-vs-Stage4
1.782170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.189800E-01
Normal-vs-AfricanAmerican
9.613000E-01
Normal-vs-Asian
3.853600E-01
Caucasian-vs-AfricanAmerican
5.499400E-01
Caucasian-vs-Asian
2.350000E-01
AfricanAmerican-vs-Asian
3.046800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.317800E-01
Normal-vs-Female
7.646200E-01
Male-vs-Female
7.618800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.129400E-01
Normal-vs-Age(41-60Yrs)
9.243600E-01
Normal-vs-Age(61-80Yrs)
6.111600E-01
Normal-vs-Age(81-100Yrs)
5.470400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.335200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.944200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.819800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.406300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.281750E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.218600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.885400E-01
Normal-vs-Daily Drinker
2.932000E-01
Normal-vs-Weekly Drinker
8.538800E-01
Normal-vs-Occasional Drinker
7.250200E-01
Normal-vs-Social Drinker
9.507200E-01
Non Drinker-vs-Daily Drinker
7.431600E-01
Non Drinker-vs-Weekly Drinker
2.380000E-01
Non Drinker-vs-Occasional Drinker
2.218000E-01
Non Drinker-vs-Social Drinker
1.220190E-01
Daily Drinker-vs-Weekly Drinker
1.591220E-01
Daily Drinker-vs-Occasional Drinker
1.282200E-01
Daily Drinker-vs-Social Drinker
7.168100E-02
Weekly Drinker-vs-Occasional Drinker
8.738200E-01
Weekly Drinker-vs-Social Drinker
8.132400E-01
Occasional Drinker-vs-Social Drinker
6.390400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.344600E-01
Normal-vs-Grade 2
8.469000E-01
Normal-vs-Grade 3
8.941200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.792840E-01
Grade 1-vs-Grade 3
5.901600E-01
Grade 1-vs-Grade 4
9.344600E-01
Grade 2-vs-Grade 3
3.444000E-01
Grade 2-vs-Grade 4
8.469000E-01
Grade 3-vs-Grade 4
8.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.276200E-01
Normal-vs-NonDiabetic
6.085400E-01
Diabetic-vs-NonDiabetic
9.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.559000E-01
Normal-vs-NoPancreatitis
6.857600E-01
Pancreatitis-vs-NoPancreatitis
3.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.467200E-01
Normal-vs-N1
7.721800E-01
N0-vs-N1
8.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.098000E-01
Normal-vs-TP53-NonMutant
7.575400E-01
TP53-Mutant-vs-TP53-NonMutant
4.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
